WuXi AppTec Co Ltd (2359.HK)

Data as of 2026-09-03.

Key facts

Price
189.30 CNY
Market capitalisation
$70.1B
P/E ratio
25.2
Dividend yield
1.03%
Sector
Health Care
Industry
Life Sciences Tools & Services
Country
CN
Exchange
SHANGHAI STOCK EXCHANGE
Employees
33 834
IPO date
2018-05-08
Stoxly score
75.0 / 100
Universe percentile
better than 88% of the analysed universe

About WuXi AppTec Co Ltd

WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company employs 33,834 full-time employees The company went IPO on 2018-05-08. WuXi AppTec Co Ltd is a China-based company principally engaged in the business of new drug research and development and manufacturing services. The firm conducts its business through six segments. The WuXi Chemistry Segment is primarily engaged in providing new drug research, development and manufacturing services. The WuXi Testing Segment is primarily engaged in providing pharmaceuticals, medical devices, and in vitro diagnostic reagents services. The WuXi Biology Segment is primarily engaged in providing drug discovery and research services. The WuXi ATU Segment is primarily engaged in providing customers with integrated medical product process development, manufacturing and testing services. The WuXi DDSU Segment is primarily engaged in providing customers with integrated new drug research and development services. The Other Segment is primarily engaged in administrative services, sales of raw materials and sales of waste materials.

Website

Similar companies

Full Quality Check for WuXi AppTec Co Ltd

Stoxly scores rate the quality of the published fundamentals, not the upside of the share price. Nothing on this page is investment advice.